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Abstract
Introduction: Substance use disorders (SUDs) are a significant US health problem affecting roughly 20
million Americans, but there continues to be limited access to SUD treatment and inadequate addiction
medicine training. Therefore, it is important to understand how SUD education is being delivered to US
health professionals, including pharmacists.
Methods: A recent survey of US pharmacy programs’ neuropsychiatry curricula was evaluated to identify any
progress made toward increasing SUD education since the last national survey in 2004 and determine any
remaining gaps between what is currently being taught and American Association of Colleges of Pharmacy
(AACP) curricular guidelines for SUD education updated in 2010. A survey of psychiatric pharmacists, regarding
what they thought should be taught, was also evaluated and compared with the 2010 AACP curricular guidelines.
Results: Our survey of US pharmacy programs demonstrated that 94% of programs reported teaching SUD
content in 2014-15, which has increased from 81% reported in a survey study from 2004. There was also an
increase for average hours of SUD didactic instruction, which increased from 2.2 hours in 2004 to 2.7 hours in
2015. The majority of members (84%) recommended at least 2 hours of SUD instruction, and 27%
recommended teaching 4 hours.
Discussion: There was an overall increase in SUD instruction, but the average hours taught still falls short of
2010 AACP curricular guideline recommendation suggesting 4 hours. Furthermore, a majority of the
psychiatric pharmacists we surveyed did not agree with the AACP curricular guideline recommendation
because only 27% of members recommended 4 hours of SUD instruction, and the average hours
recommended was only 2.7 hours.
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Introduction
Substance use disorders (SUDs) are a significant US health
problem affecting 20.5 million Americans (12 years of age
or older) during 2015.1 According to the 2015 National
Survey on Drug Use and Health, about 15 million adults
had an alcohol use disorder, and based on data from
2006-10, an estimated 88 000 Americans die annually due
to alcohol-related causes.2 There are also approximately
2.5 million Americans suffering from a prescription opioid
or heroin SUD, with roughly 30 000 opioid-related
overdose deaths in 2015.1 Despite America’s clear
substance use problem, there continues to be limited
access to SUD treatment and inadequate addiction
medicine training.3 Therefore, it is important to under-
stand what SUD education is being provided to health
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professionals, including pharmacists, and how this com-
pares to expert panel recommendations.
In a 2004 survey study, 81% of pharmacy programs
provided SUD education in their clinical therapeutics
courses with an average of 2.2 hours (SD¼2.2 hours)
lecture-based instruction and 0.5 hours (SD¼ 1.4 hours)
case-based instruction.4 Only 2 of the 49 pharmacy
schools surveyed required an advanced pharmacy practice
experience (APPE) in psychiatry, the practice setting
where SUDs are typically managed.4 However, more than
90% of the schools offered a psychiatry elective rotation
with a mean annual enrollment rate of 20.2% (SD ¼
19.5%).4
Practicing Florida pharmacists surveyed in 2005 also
demonstrated limited education in SUDs because the
majority (67.5%) of the 454 respondents recalled receiving
2 hours or less of addiction/substance abuse education in
pharmacy school, and some even indicated no addiction
education (29.2%).5 Less than half (46.7%) of the
respondents reported having ‘‘very much’’ or ‘‘much’’
knowledge about how to intervene or counsel patients
regarding medications that were potentially addictive.5
One limitation of this study was the potential for recall
bias because most of these pharmacists completed their
pharmacy education during previous decades. Indiana
licensed pharmacists surveyed in 2009 had a strong
interest in learning more about substance abuse, and
22.2% of the pharmacists sought additional independent
addiction education.6 They also reported spending a mean
of 6.94% of their day with customers who have chemical
dependency issues, which further highlighted the gap
between the limited SUD education that pharmacists
received and the amount of time they dedicated to
chemically dependent patients in their daily practice.6
Recognizing the important role for pharmacists in
providing care to patients with SUDs, the American
Association of Colleges of Pharmacy (AACP) special
committee on substance abuse and pharmacy education
updated and revised the document ‘‘Curricular Guidelines
for Pharmacy: Substance Abuse and Addictive Disease’’ in
2010 and ‘‘suggested that at least 4 hours be devoted to
the identification, intervention, and treatment of addic-
tion and related disorders,’’7(p6) which ‘‘should prepare
the student pharmacist to competently problem-solve
issues concerning alcohol and other drug abuse and
addictive diseases affecting patients, families, colleagues,
themselves, and society.’’7(p1) The AACP curricular guide-
lines also suggested that student or professional peer
assistance programs should be introduced within the first
month after new student orientation and that psychoso-
cial aspects of substance use be covered within the first 3
semesters. As pharmacy programs consider increasing the
emphasis on SUD education in their curricula, it is
important to evaluate and assess the progress made
since the last national pharmacy curriculum survey was
conducted in 2004 and compare to 2010 AACP curricular
guidelines.4,7,8
Methods
The survey data was derived from 2 surveys completed
during 2015: 1 of US pharmacy programs and 1 of College
of Psychiatric and Neurologic Pharmacists (CPNP) mem-
bers with a teaching affiliation.9 These 2 surveys
attempted to capture a representative national sample
of accredited pharmacy programs in the United States
and teaching psychiatric pharmacists. The first survey
asked curriculum representatives from pharmacy pro-
grams to answer questions about clinical therapeutics
course topics taught during the 2014-15 academic year.
The second survey asked CPNP members with an
academic affiliation and a board certified psychiatric
pharmacist credential to provide recommendations re-
garding what should be taught in neuropsychiatric
curricula.
Results
The response rate for the pharmacy program survey was
56% with 75/133 of program representatives submitting at
least partial survey data.9 Of the responding programs
reporting therapeutics didactic course content, 94%
reported teaching SUDs during the 2014-15 academic
year curriculum with the majority (56%) delivering SUD
content during year 3 of pharmacy school, 31% teaching in
year 2, and only 3% reported teaching during year 1. The
average time of instruction reported was 2.7 hours
(SD¼ 1.5 hours) with 79% of programs reporting at least
2 hours and only 30% of the programs teaching 4 hours.
The majority of instructors teaching SUDs in therapeutics
didactic lectures were full time (81%) and had the board
certified psychiatric pharmacist credential (51%). A few
respondents also reported covering content in team-based
learning, learning labs, and flipped classroom settings.
There were minimal APPE rotations available that were
specifically focused on SUDs or addiction medicine
because only 17 programs reported such a practice site.
The number of rotation student placements available at
these programs ranged from 1 to 18 students per year.
The response rate for the CPNP member survey was 65%
(173/267).9 The majority of members (84%) recommended
at least 2 hours of SUD instruction, and 27% recommend-
ed teaching 4 hours. This put SUD in fourth place out of
the 20 topics surveyed, with only epilepsy, schizophrenia,
and pain syndromes having a greater percentage of
members who recommended 4 hours. These members
Ment Health Clin [Internet]. 2018;8(1):14-7. DOI: 10.9740/mhc.2018.01.014 15
surveyed recommended an average of 2.7 hours (SD¼ 1.3
hours) for SUD didactic instruction.
Discussion
Substance use disorders are a significant US health
problem, and there is a need to improve education for
the public and health professionals, including pharmacy
students. The survey data demonstrated that there may
be a higher proportion of programs now teaching SUDs in
therapeutics courses with 94% of programs in 2015
compared to 81% in a previous 2004 survey study.4 The
current survey also shows that 79% of programs are
reporting at least 2 hours of SUD education during the
2014-15 academic year, which appears to have increased
compared to a previous survey from 2005.5 In this 2005
study, the majority (67.5%) of practicing Florida pharma-
cists reported 2 hours and roughly one third reported no
education about addiction/substance abuse.5
The 2010 AACP curricular guidelines recommend that
teaching psychosocial aspects of alcohol and other drug
use should be ‘‘initiated within the first 3 semesters of the
pharmacy curriculum within required courses.’’7(p4) Our
survey shows that only 34% of programs are potentially
meeting this recommendation by offering SUD education
in year 1 or 2 of pharmacy school.
The AACP also states, ‘‘it is suggested that at least four
hours be devoted to the identification, intervention and
treatment of addiction and related disorders, possibly
during a pharmacotherapeutics course sequence.’’7(p6)
Based on our survey results, it appears that 70% of
pharmacy programs are not currently meeting this
recommendation and that the majority of CPNP
members actually disagreed with this AACP recommen-
dation because only 27% of respondents suggested that
4 hours of SUD should be taught. Epilepsy, schizo-
phrenia, and pain syndromes were the only 3 topics that
were recommended for more teaching hours (4 hours)
than SUD in the member survey. Pharmacy instructors
may possibly consider 4 hours too long for most topics,
and perhaps other researchers will consider evaluating
educational outcomes in the future to determine the
most appropriate number of hours for SUD education in
pharmacotherapeutics courses.
The AACP curricular guidelines recommend that students
should be provided with required and elective opportuni-
ties through a variety of teaching approaches, including
lectures, reading assignments, group discussions, term
papers, and recorded or printed media.7 They further
explain that ‘‘potential elective experiences could include
visits to substance abuse resource centers, treatment
agencies, and self-help groups (especially those based on
the 12 steps of Alcoholics Anonymous).’’7(p4) Our survey
results demonstrated that SUD APPE rotations were quite
limited with only 23% of programs offering SUD-specific
practice sites, which suggests many pharmacy programs
may not be meeting the experiential component of this
AACP recommendation. It is also important to consider
that some elements of SUD education may be covered in
other practice settings, such as alcohol withdrawal during
an emergency or internal medicine rotation.
The consistency between what programs reported and
what CPNP members thought should be taught (2.7
hours) may highlight a potential status quo bias,
particularly if CPNP members completed both the
individual member survey and the survey on behalf of
the US pharmacy program. Other limitations to our survey
data include using 1 hour as the unit of analysis for
averages when respondents reported topic times in the
0.1 to 1 hour range. Our sample is also susceptible to recall
bias and potential inaccuracy because it was possible that
multiple program contacts filled out various portions of
the program surveys, with some programs only partially
completing questions and others not responding at all.
Although SUDs remain a significant US public health
problem, and 2010 AACP curricular guidelines have
suggested how to implement SUD education, it appears
that most US pharmacy programs have not adopted these
recommendations, and only about a quarter of CPNP
members agreed that 4 hours of SUD education should
be taught. Although the AACP provides some curricular
guidance, there still remains an unmet need for pharmacy
educators to identify the most salient SUD content for
therapeutics courses, develop updated curricula, and
evaluate educational outcomes to ensure that all student
pharmacists are competent to manage patients with
SUDs.
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